Bone Health

A Brief Update of the Current Landscape of Bone Targeted Therapies for Prostate Cancer

Prostate cancer tends to metastasize to bones as opposed to soft tissue and other organs. We have no idea why it does have a preference for bone, but it does. Developing bone metastases in prostrate cancer is a very strong negative prognostic indicator. Prostate cancer’s tendency to favor bone over soft tissue causes significant morbidity [...]

By Malecare|2016-10-14T13:14:25-04:00October 14th, 2016|Advanced Prostate Cancer, Alpharadin (radium-223), bisphosphonates, Bone Metastases, Bones and Prostate Cancer, Drugs & Treatments, Survival, Uncategorized, Understanding Advanced Prostate Cancer, Xgeva, Xofigo, Zometa|2 Comments

Bone Complications Among Prostate Cancer Survivors Having Prolonged Hormone Therapy (ADT)

Androgen deprivation therapy (ADT) and bone complications are the two near universals for men with advanced prostate cancer. A long-term follow up of fifteen (15) years after diagnosis of a population-based cohort of prostate cancer survivors proved to be very informative. The Prostate Cancer Outcomes Study, which enrolled 3533 men diagnosed with prostate cancer between [...]